Before discussing any peptide, a physician may want to know how the injury started, how long symptoms have been present, what makes it worse, whether strength or range of motion changed, whether imaging is needed, what therapies have already been tried, and whether there are systemic factors slowing recovery
76 Exenatide is composed of 39 amino acids and shares 53% sequence identity to human GLP-1
MOTS-c acts through AMPK activation, the same pathway triggered by metformin and physical exercise [2]
Promotes energy metabolism
AP24534, a pan-BCR-ABL inhibitor for chronic myeloid leukemia, potently inhibits the T315I mutant and overcomes mutation-based resistance